Alimentary Pharmacology & Therapeutics

Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP)
pp. 103-116(14)
Authors: Subhani,; Kibbler,; Dooley,

Review article: Helicobacter pylori and gastro-oesophageal reflux disease—clinical implications and management
pp. 117-127(11)
Author: O'connor,

Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications
pp. 129-133(5)
Authors: Jones,; Simpson,

Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders
pp. 135-144(10)
Authors: Perner,; Rask-Madsen,

Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study
pp. 145-153(9)
Authors: Sanduleanu,; Stridsberg,; Jonkers,; Hameeteman,; Biemond,; Lundqvist,; Lamers,; Stockbrügger,

Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus—evaluation of 24-h pH monitoring
pp. 155-162(8)
Authors: Haruma,; Mihara,; Okamoto,; Kusunoki,; Hananoki,; Tanaka,; Yoshihara,; Sumii,; Kajiyama,

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy
pp. 163-168(6)
Authors: Rinaldi,; Zullo,; Francesco,; Hassan,; Winn,; Stoppino,; Faleo,; Attili,

Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection
pp. 169-172(4)
Authors: Graham,; Hoffman,; Anderson,; Qureshi,; Osato,; El-Zimaity,

Failure of a 1-day high-dose quadruple therapy for cure of Helicobacter pylori infection
pp. 173-177(5)
Authors: Wermeille,; Cunningham,; Armenian,; Zelger,; Buri,; Merki,; Hadengue,

Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study
pp. 179-186(8)
Authors: Dekkers,; Beker,; Thjodleifsson,; Gabryelewicz,; Bell,; Humphries,

Protection of human gastric mucosa against aspirin—enteric coating or dose reduction?
pp. 187-193(7)
Authors: Cole,; Hudson,; Liew,; Murray,; Hawkey,; Heptinstall,

Indomethacin-induced gastric antral damage in hamsters: are neutrophils involved?
pp. 195-202(8)
Authors: Fitzpatrick,; Sakurai,; Le,

Protective effects of zinc in indomethacin-induced gastric mucosal injury: evidence for a dual mechanism involving lipid peroxidation and nitric oxide
pp. 203-208(6)
Authors: Joseph,; Varela,; Kanji,; Subramony,; Mihas,

Glucose metabolism and insulin sensitivity in inactive inflammatory bowel disease
pp. 209-217(9)
Authors: Capristo,; Mingrone,; Addolorato,; Greco,; Gasbarrini,

A cortisol suppression dose-response comparison of budesonide in controlled ileal release capsules with prednisolone
pp. 219-224(6)
Authors: Edsbäcker,; Nilsson,; Larsson,

Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index
pp. 225-235(11)
Authors: Talley,; Haque,; Wyeth,; Stace,; Tytgat,; Stanghellini,; Holtmann,; Verlinden,; Jones,

Gastric emptying in hyperemesis gravidarum and non-dyspeptic pregnancy
pp. 237-243(7)
Authors: Maes,; Spitz,; Ghoos,; Hiele,; Evenepoel,; Rutgeerts,

The effect of curcumin and placebo on human gall-bladder function: an ultrasound study
pp. 245-249(5)
Authors: Rasyid,; Lelo,

Combination therapy of pentoxifylline and TNFα monoclonal antibody in dextran sulphate-induced mouse colitis
pp. 251-260(10)
Authors: Murthy,; Cooper,; Yoshitake,; Meyer,

Polaprezinc protects gastric mucosal cells from noxious agents through antioxidant properties in vitro
pp. 261-269(9)
Authors: Hiraishi,; Sasai,; Oinuma,; Shimada,; Sugaya,; Terano,